文献速递心脑血管急症重症综合管理与镇静镇痛

血浆脑心磷脂脂质组学检测与心脏骤停后结局相关

Lipidomics Detection of Brain Cardiolipins in Plasma Is Associated With Outcome After Cardiac Arrest.
PubMed 文献 · Crit Care Med · 2019-01-01
一句话结论心脏骤停自主循环恢复后6小时内血浆中出现脑特异性心磷脂,其脑评分与早期神经损伤及出院神经功能结局相关,心磷脂(70:5)可能是床旁标志物。

该观察性病例对照研究纳入41例成人心脏骤停患者(最终分析39例),在自主循环恢复后6小时内采血,另设5例心肌梗死和10例健康对照,并采用Sprague-Dawley大鼠窒息性心脏骤停模型。研究者建立高分辨率液相色谱/质谱法,发现人脑心磷脂组多样性高于心脏,可鉴定脑特异性心磷脂;26种脑特异性心磷脂中9种可在血浆中检出并与脑损伤相关,脑评分与早期神经损伤相关并预测出院神经功能结局,心磷脂(70:5)成为预测损伤严重程度和结局的潜在床旁标志物。大鼠模型中,海马心磷脂显著减少对应其从脑释放入体循环,脑评分在无血流10分钟组较5分钟组及 naive 对照组显著升高。结论认为脑特异性心磷脂在自主循环恢复后早期积聚于血浆且与神经损伤程度成比例,是有前景的新型生物标志物。

要点

  • 心脏骤停自主循环恢复后6小时内,血浆中可检出9种脑特异性心磷脂,并与脑损伤相关。
  • 由脑特异性心磷脂衍生的脑评分与早期神经损伤相关,并预测出院神经功能结局。
  • 心磷脂(70:5)为潜在床旁标志物,可预测损伤严重程度和结局。
  • 大鼠窒息性心脏骤停模型中,海马心磷脂显著减少,对应其释放入体循环;无血流10分钟组脑评分较5分钟组及naive对照组显著升高。
  • 人脑心磷脂组多样性高于心脏,使脑特异性心磷脂的鉴定成为可能。

适用人群与场景

  • 成人心脏骤停患者,自主循环恢复后6小时内可获取血标本者;最终分析39例(原纳入41例,2例因离群值分析排除)。
  • 对照包括10例健康受试者和5例心肌梗死患者。
  • 动物实验使用Sprague-Dawley大鼠窒息性心脏骤停模型。

研究设计与关键结果

  • 研究类型为观察性病例对照研究,在两个医疗中心进行,纳入41例成人心脏骤停患者(最终分析39例)、5例心肌梗死患者和10例健康对照,并使用Sprague-Dawley大鼠窒息性心脏骤停模型。
  • 人脑心磷脂组多样性高于心脏,可鉴定脑特异性心磷脂;26种脑特异性心磷脂中9种可在血浆中检出并与脑损伤相关。
  • 脑评分与早期神经损伤相关,并预测出院神经功能结局;心磷脂(70:5)为潜在床旁标志物,可预测损伤严重程度和结局。
  • 大鼠心脏骤停模型中,海马心磷脂显著减少,对应其从脑释放入体循环;脑评分在无血流10分钟组较5分钟组及naive对照组显著升高。

证据类型、等级与局限

  • 证据类型:观察性病例对照研究(含大鼠实验),原文未报告证据等级或推荐强度。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为脑特异性心磷脂在自主循环恢复后早期积聚于血浆且与神经损伤程度成比例,是有前景的新型生物标志物;心磷脂(70:5)为潜在床旁标志物,可预测损伤严重程度和结局。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVES: Brain mitochondrial dysfunction limits neurologic recovery after cardiac arrest. Brain polyunsaturated cardiolipins, mitochondria-unique and functionally essential phospholipids, have unprecedented diversification. Since brain cardiolipins are not present in plasma normally, we hypothesized their appearance would correlate with brain injury severity early after cardiac arrest and return of spontaneous circulation.

DESIGN: Observational case-control study.

SETTING: Two medical centers within one city.

PARTICIPANTS (SUBJECTS): We enrolled 41 adult cardiac arrest patients in whom blood could be obtained within 6 hours of resuscitation. Two subjects were excluded following outlier analysis. Ten healthy subjects were controls. Sprague-Dawley rats were used in asphyxial cardiac arrest studies.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: We developed a high-resolution liquid chromatography/mass spectrometry method and determined cardiolipins speciation in human brain, heart, and plasma within 6 hours of (return of spontaneous circulation) from 39 patients with cardiac arrest, 5 with myocardial infarction, and 10 healthy controls. Cerebral score was derived from brain-specific cardiolipins identified in plasma of patients with varying neurologic injury and outcome. Using a rat model of cardiac arrest, cardiolipins were quantified in plasma, brain, and heart. Human brain exhibited a highly diverse cardiolipinome compared with heart that allowed the identification of brain-specific cardiolipins. Nine of 26 brain-specific cardiolipins were detected in plasma and correlated with brain injury. The cerebral score correlated with early neurologic injury and predicted discharge neurologic/functional outcome. Cardiolipin (70:5) emerged as a potential point-of-care marker predicting injury severity and outcome. In rat cardiac arrest, a significant reduction in hippocampal cardiolipins corresponded to their release from the brain into systemic circulation. Cerebral score was significantly increased in 10 minutes versus 5 minutes no-flow cardiac arrest and naïve controls.

CONCLUSIONS: Brain-specific cardiolipins accumulate in plasma early after return of spontaneous circulation and proportional to neurologic injury representing a promising novel biomarker.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Anthonymuthu TS, Kenny EM, Lamade AM, et al. Lipidomics Detection of Brain Cardiolipins in Plasma Is Associated With Outcome After Cardiac Arrest. Crit Care Med. 2019. PMID: 30855329. doi:10.1097/CCM.0000000000003636

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。